MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest and dividend
income
$5,139K
Net loss
-$57,591K
Total other income,
net
$5,134K
Unrealized loss on
short-term investments
-$5K
Loss from operations
-$62,725K
Total operating
expenses
$62,725K
Research and development
$48,936K
General and
administrative
$13,789K
Back
Back
Income Statement
source: myfinsight.com
Aardvark Therapeutics, Inc. (AARD)
Aardvark Therapeutics, Inc. (AARD)